Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

Explaining Phenotypes

In the latest issue of FLG magazine we met a biochemist at the intersection of metabolomics and genomics: Greg Michelotti of Metabolon